KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $260.68 $288.54 Thursday, 25th Apr 2024 AMGN stock ended at $269.38. This is 1.33% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.66% from a day low at $267.24 to a day high of $274.35.
90 days $260.68 $329.72
52 weeks $211.73 $329.72

Historical Amgen Inc. prices

Date Open High Low Close Volume
Nov 30, 2023 $267.71 $270.56 $267.34 $269.64 2 192 592
Nov 29, 2023 $264.74 $268.11 $263.50 $266.60 1 884 461
Nov 28, 2023 $264.36 $266.60 $263.65 $265.52 1 582 304
Nov 27, 2023 $265.43 $265.43 $261.66 $264.27 1 503 259
Nov 24, 2023 $265.12 $266.10 $264.89 $265.46 656 313
Nov 22, 2023 $264.79 $266.47 $262.26 $264.59 1 469 509
Nov 21, 2023 $265.34 $266.04 $260.52 $262.82 2 274 332
Nov 20, 2023 $262.59 $266.70 $261.45 $265.35 2 134 136
Nov 17, 2023 $269.41 $269.41 $264.60 $265.39 2 506 959
Nov 16, 2023 $272.61 $274.44 $267.87 $269.00 2 237 575
Nov 15, 2023 $270.28 $274.61 $270.10 $273.03 2 782 459
Nov 14, 2023 $269.22 $272.95 $268.36 $270.02 2 058 536
Nov 13, 2023 $265.68 $267.20 $263.53 $266.69 1 484 224
Nov 10, 2023 $266.64 $267.94 $262.51 $267.31 2 018 174
Nov 09, 2023 $272.13 $273.00 $263.70 $264.06 2 245 371
Nov 08, 2023 $272.42 $274.77 $270.75 $273.26 1 782 570
Nov 07, 2023 $272.97 $274.00 $269.38 $271.11 2 142 740
Nov 06, 2023 $270.77 $274.95 $270.75 $272.83 2 537 767
Nov 03, 2023 $268.52 $270.55 $265.50 $269.86 2 371 729
Nov 02, 2023 $263.30 $268.10 $262.46 $266.59 2 359 153
Nov 01, 2023 $256.27 $261.19 $255.09 $260.84 2 492 113
Oct 31, 2023 $255.89 $257.42 $249.70 $255.70 4 588 499
Oct 30, 2023 $265.00 $266.35 $262.50 $263.19 2 813 905
Oct 27, 2023 $268.95 $268.95 $260.16 $261.57 2 637 884
Oct 26, 2023 $271.50 $273.44 $269.16 $269.71 2 077 859
Click to get the best stock tips daily for free!

About Amgen Inc.

Amgen. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus... AMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT